Primary hyperaldosteronism Screening

Primary hyperaldosteronism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary Hyperaldosteronism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
CT scan Findings
MRI Findings
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Primary hyperaldosteronism Screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Primary hyperaldosteronism Screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Primary hyperaldosteronism Screening
CDC on Primary hyperaldosteronism Screening
Primary hyperaldosteronism Screening in the news
Blogs on Primary hyperaldosteronism Screening
Directions to Hospitals Treating Conn syndrome
Risk calculators and risk factors for Primary hyperaldosteronism Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Screening

The following indviduals should be screened for primary hyperaldosteronism:

1. Blood pressure > 160 / 100 particularly (< 50 years)
2. Resistant hypertension or refractory hypertension (use of > 3 anti-hypertensives and poor control of blood pressure)
3. Hypokalemia (provoked by diuretic therapy or unprovoked)
4. Hypertension and incidentally discovered adrenal adenoma
5. Hypertension with a family history of early-onset hypertension (< 20 years) or cerebrovascular accident at age less than 40 years
6. Hypertensive first-degree relatives of patients with PA